January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

Analysis of Nokia's Q4/2024 earnings: beating estimates, strong margins, cash generation, strategic acquisitions driving growth outlook.

Corcept Therapeutics Inc. (NASDAQ:CORT) has reached an unprecedented milestone as its stock price soared to an all-time high of $70.78. This remarkable peak reflects a significant surge in investor ...

Novartis stock rose slightly early Friday after the company beat expectations. But the Street is closely watching for Entresto generics.

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.